Pages that link to "Q50277148"
Jump to navigation
Jump to search
The following pages link to Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: the ATROCAP study (Q50277148):
Displaying 18 items.
- Anticoagulants and Statins As Pharmacological Agents in Free Flap Surgery: Current Rationale (Q26776077) (← links)
- Ongoing clinical trials of the pleiotropic effects of statins (Q28219321) (← links)
- Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke (Q34095488) (← links)
- Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes (Q35200997) (← links)
- The cardioprotective effects of statins (Q35602770) (← links)
- Atherosclerosis: from biology to pharmacological treatment (Q36313684) (← links)
- The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation (Q36536154) (← links)
- Statins as first-line therapy for acute coronary syndrome? (Q36768488) (← links)
- Effects of atorvastatin on the different phases of atherogenesis (Q36957799) (← links)
- Statins in the first-line therapy of acute coronary syndrome - similar to aspirin? (Q37276466) (← links)
- Potential use of statins in the treatment of antiphospholipid syndrome. (Q37959316) (← links)
- Lipid Control and Beyond: Current and Future Indications for Statin Therapy in Stroke (Q38751939) (← links)
- Atorvastatin upregulates apolipoprotein M expression via attenuating LXRα expression in hyperlipidemic apoE-deficient mice (Q57787121) (← links)
- Can we stabilize unstable plaque? (Q79116704) (← links)
- High HDL cholesterol level after treatment with pitavastatin is an important factor for regression in carotid intima-media thickness (Q87157196) (← links)
- Stabilization of symptomatic carotid atherosclerotic plaques by statins: a clinico-pathological analysis (Q88779697) (← links)
- Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial (Q90631519) (← links)
- Different Types of Statins and All-Cause Mortality during Anticoagulation for Venous Thromboembolism: Validation Study from RIETE Registry (Q99610068) (← links)